VesCell™ Stem Cell Therapy for Heart Disease and Peripheral Artery Disease  
 
Stem Cell Therapy Homepage Stem Cell Therapy Links Stem Cell Therapy Sitemap Contact VesCell™ for More Stem Cell Therapy Information
     
    Contact VesCell™ for More Stem Cell Therapy Information
home
Meet VesCell stem cell patients in video interviews - stem cell treatment success stories!
  Meet Our Patients
  Patient Videos
Updated news about VesCell adult stem cell treatment for heart disease and peripheral artery disease from VesCell founder. Moreover, good news about adult stem cell treats diabetes and excellent treating result from VesCell patient.
  A Special Message
  Founder and Friends
Contact VesCell and talk with one of our professionals about Heart Disease or Peripheral Artery Disease Treatment options, or any general enquiries you may have..
  Heart Treatment Inquiry
  PAD Treatment Inquiry
  FREE Newsletter!
  Other Inquiry
VesCell Adult Stem Cell Information - Stem Cell Therapy & Treatment explained
  VesCell
  VesCell Process Slide Show
  VesCell Heart Disease FAQ
  VesCell for PAD FAQ
  Stem Cells
  Treating Physicians
  Partner Hospitals
  Scientific Advisory Board
Stem Cell Research Articles, International Stem Cell Therapy, Treatment News & Events
  Don Ho - Remembered
  VesCell in the News
  Regenocyte in the News
  Press Releases
  Events
  Accreditations
Stem Cell Treatment Information for Congestive Heart Failure, Cardiomyopathy, Peripheral & Coronary Artery Disease Patients
  Heart Disease
  Congestive Heart Failure
  Cardiomyopathy
  Coronary Artery Disease
  Peripheral Artery Disease

Australian Man Claims New Stem Cell Treatment Saved His Life November 27, 2007

Posted by TheraVitae in : Press Releases , trackback

Queensland Native Can Laugh Again After Stem Cell Therapy
Queensland, Australia 11/27/2007 03:29 AM GMT (TransWorldNews)

Mick Fleming, 73, of Queensland, Australia had given up hope. His heart condition had incapacitated him so much that he couldn’t even dress himself. Mick told his son, Keith, “I give up. I’m going to die.” Keith refused to accept that and answered, “You will not die until I give you permission!” Keith Fleming knew something had to be done. He scoured the internet looking for help.

That is when he found Theravitae, an international biotechnology company that specializes in treating heart patients suffering from coronary heart disease, congestive heart failure, and cardiomyopathy with their Vescell adult stem cell therapy.

Keith contacted Theravitae and made the arrangements to come to Bangkok, Thailand so his father could receive his stem cell treatment.

Mick’s wife, Phyllis described the experience in Thailand. “I don’t have enough praise for Theravitae. From the moment we arrived at the airport, we couldn’t have wished for better care.”

“The hospital was brilliant. The cleanest hospital I have ever seen. No hospital in Australia can stand up to it. The doctor spent over an hour with us explaining the procedure. That is unheard of here in Australia,” she said.

Mick was treated with his own stem cells in a non-invasive procedure very similar to an angioplasty.

Since receiving the adult stem cell therapy, Mick has shown steady improvement. Phyllis says, “Prior to going, he couldn’t do anything. He couldn’t even dress himself. Now, not only is he dressing himself, he can do far more for himself than before.”

Phyllis continued, “His sense of humor is back. He is laughing again. It was worth every penny. Going to Thailand for the stem cell treatment was the best thing we ever did. It gave Mick the will to live again, a new life.”

Mick said, “I have absolutely no doubt that your Vescell stem cell treatment saved my life. Both my cardiac surgeon and my general practitioner told me there was nothing they could do and the general opinion was that I would not see another Christmas. A pleasant side effect is that my Type II Diabetes has improved tremendously. I am on half the insulin I needed before the stem cell treatment.”

Phyllis says that Mick and Keith and herself are willing to talk to anyone about Theravitae’s adult stem cell therapy, “We are willing to do whatever we can to help. It is so important that people know about this.”

About TheraVitae:
TheraVitae is a private, multinational company focused on using stem cells from the patient’s own blood in order to treat a variety of disorders, especially cardiovascular diseases. The company has developed a proprietary stem cell technology, ‘VesCell’, that is currently being used by hospitals in Thailand and Singapore to treat patients with heart disease and peripheral artery disease.

VesCell — A Natural Treatment for Heart Disease and Peripheral Arterial Disease (PAD)
The body has natural ways of healing itself and the cardiovascular system is no exception. Angiogenic Cell Precursors (ACPs) originate in bone marrow and then circulate in the blood vessels. To manufacture VesCell, TheraVitae expands a small number of ACPs harvested from about 250cc of blood into a therapeutic quantity. VesCell is injected either through a coronary artery via catheter, or during surgery, directly into the heart muscle.

A key aspect of VesCell therapy is the advanced cell isolation and expansion technique that allows for the ACPs to be harvested from blood collected in a procedure similar to a common blood donation. VesCell uses a patient’s own adult stem cells to treat Heart Disease and PAD and is a viable therapeutic possibility for heart or PAD patients without any other treatment option.

jerry@theravitae.com
www.vescell.com